What is the speed limit of martensitic transformations? von Schwabe, Stefan, Lünser, Klara, Schmidt, Daniel, Nielsch, Kornelius, Gaal, Peter, Fähler, Sebastian

Volltext

Effect of Topiramate or Carbamazepine on the Pharmacokinetics of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol in Healthy Obese and Nonobese Female Subjects von Doose, Dennis R., Wang, Shean‐Sheng, Padmanabhan, Mukund, Schwabe, Stefan, Jacobs, David, Bialer, Meir

Volltext

Building Hierarchical Martensite von Schwabe, Stefan, Niemann, Robert, Backen, Anja, Wolf, Daniel, Damm, Christine, Walter, Tina, Seiner, Hanuš, Heczko, Oleg, Nielsch, Kornelius, Fähler, Sebastian

Volltext

New Insights into the Mechanism of Action of Viloxazine: Serotonin and Norepinephrine Modulating Properties von Yu, Chungping, Garcia-Olivares, Jennie, Candler, Shawn, Schwabe, Stefan, Maletic, Vladimir

Volltext

A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperacti... von Nasser, Azmi, Hull, Joseph T., Chaturvedi, Soumya A., Liranso, Tesfaye, Odebo, Oyinkansola, Kosheleff, Alisa R., Fry, Nicholas, Cutler, Andrew J., Rubin, Jonathan, Schwabe, Stefan, Childress, Ann

Volltext

A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hypera... von Nasser, Azmi, Liranso, Tesfaye, Adewole, Toyin, Fry, Nicholas, Hull, Joseph T., Chowdhry, Fatima, Busse, Gregory D., Cutler, Andrew J., Jones, Nandita Joshi, Findling, Robert L., Schwabe, Stefan

Volltext

Viloxazine in the Management of CNS Disorders: A Historical Overview and Current Status von Findling, Robert L., Candler, Shawn A., Nasser, Azmi F., Schwabe, Stefan, Yu, Chungping, Garcia-Olivares, Jennie, O’Neal, Welton, Newcorn, Jeffrey H.

Volltext

Topiramate and Lamotrigine Pharmacokinetics during Repetitive Monotherapy and Combination Therapy in Epilepsy Patients von Doose, Dennis R., Brodie, Martin J., Wilson, Elaine A., Chadwick, David, Oxbury, John, Berry, David J., Schwabe, Stefan, Bialer, Meir

Volltext

Population Pharmacokinetics of Viloxazine Extended‐Release Capsules in Pediatric Subjects With Attention Deficit/Hyperactivity Disorder von Nasser, Azmi, Gomeni, Roberto, Wang, Zhao, Kosheleff, Alisa R., Xie, Lanyi, Adeojo, Lilian W., Schwabe, Stefan

Volltext

Hierarchical Martensite: Building Hierarchical Martensite (Adv. Funct. Mater. 7/2021) von Schwabe, Stefan, Niemann, Robert, Backen, Anja, Wolf, Daniel, Damm, Christine, Walter, Tina, Seiner, Hanuš, Heczko, Oleg, Nielsch, Kornelius, Fähler, Sebastian

Volltext

1.70 A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY (P301) ASSESSING THE EFFICACY AND SAFETY OF SPN-812 (EXTENDED-RELEASE VILOXAZINE) 100 AND 200MG FOR THE TREATMENT... von Nasser, Azmi, Busse, Gregory D., Hull, Joseph, Chowdhry, Fatima, Adewole, Toyin, Liranso, Tesfaye, Schwabe, Stefan

Volltext

1.71 A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY (P302) ASSESSING THE EFFICACY AND SAFETY OF SPN-812 (EXTENDED-RELEASE VILOXAZINE) 200 AND 400MG FOR THE TREATMENT... von Nasser, Azmi, Busse, Gregory D., Hull, Joseph, Chowdhry, Fatima, Adewole, Toyin, Liranso, Tesfaye, Schwabe, Stefan

Volltext

1.72 A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY (P303) ASSESSING THE EFFICACY AND SAFETY OF SPN-812 (EXTENDED-RELEASE VILOXAZINE) 200 AND 400 MG FOR THE TREATMEN... von Nasser, Azmi, Busse, Gregory D., Hull, Joseph, Chowdhry, Fatima, Adewole, Toyin, Liranso, Tesfaye, Schwabe, Stefan

Volltext

Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Methylphenidate in Healthy Adults von Faison, Shamia L., Fry, Nicholas, Adewole, Toyin, Odebo, Oyinkansola, Schwabe, Stefan, Wang, Zhao, Maletic, Vladimir, Nasser, Azmi

Volltext

Once-Daily SPN-812 200 and 400 mg in the treatment of ADHD in School-aged Children: A Phase III Randomized, Controlled Trial von Nasser, Azmi, Liranso, Tesfaye, Adewole, Toyin, Fry, Nicholas, Hull, Joseph T., Chowdhry, Fatima, Busse, Gregory D., Melyan, Zare, Cutler, Andrew J., Findling, Robert L., Schwabe, Stefan

Volltext

5.31 THE EFFICACY AND SAFETY OF SPN-812 (VILOXAZINE EXTENDED-RELEASE) FOR THE TREATMENT OF ADHD IN CHILDREN AND ADOLESCENTS von Nasser, Azmi, Hull, Joseph T., Chaturvedi, Soumya, Adewole, Toyin, Liranso, Tesfaye, Busse, Greg, Jain, Rakesh, Schwabe, Stefan

Volltext

A Phase II Double-Blind, Placebo-Controlled, Efficacy and Safety Study of SPN-812 (Extended-Release Viloxazine) in Children With ADHD von Johnson, Janet K., Liranso, Tesfaye, Saylor, Keith, Tulloch, Gabriela, Adewole, Toyin, Schwabe, Stefan, Nasser, Azmi, Findling, Robert L., Newcorn, Jeffrey H.

Volltext

A Double-Blind, Randomized Study of Extended-Release Molindone for Impulsive Aggression in ADHD von Ceresoli-Borroni, Gianpiera, Nasser, Azmi, Adewole, Toyin, Liranso, Tesfaye, Xu, Jiahong, Schwabe, Stefan, Findling, Robert L.

Volltext

Cognitive Effects of Extended-Release Once-Daily SPN-538 (Trokendi XR™) vs b.i.d. Immediate-Release Topiramate (TPM-IR, Topamax®) in Healthy Volunteers (S43.002) von Johnson, Janet, Brittain, Scott, Schwabe, Stefan

Volltext

Topiramate for Migraine Prevention: A Randomized Controlled Trial von Brandes, Jan Lewis, Saper, Joel R, Diamond, Merle, Couch, James R, Lewis, Donald W, Schmitt, Jennifer, Neto, Walter, Schwabe, Stefan, Jacobs, David, for the MIGR-002 Study Group

Volltext